GSTC OTC
GlobeStar Therapeutics Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.5%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
-47.4% ▼
Net Income
-$2M
-31.0% ▼
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
$7K
+100.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $425 | $77 | $0 | $0 | $0 |
| YoY Growth | -52.2% | -81.9% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $154 | $38K | $2K | $0 | $0 |
| Gross Profit | $271 | -$38K | -$2K | $0 | $0 |
| Gross Margin | 63.8% | -48837.7% | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $316K | $266K | $9M | $1M | $2M |
| Operating Expenses | $316K | $266K | $9M | $1M | $2M |
| Operating Income | -$316K | -$304K | -$9M | -$1M | -$2M |
| Operating Margin | -74352.9% | -394805.2% | — | — | — |
| Interest Expense | $360K | $238K | $287K | $70K | $92K |
| Income Before Tax | -$675K | -$542K | -$10M | -$1M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$675K | -$542K | -$10M | -$1M | -$2M |
| Net Margin | -158823.5% | -703896.1% | — | — | — |
| EPS (Diluted) | $-0.02 | $-0.00 | $-0.02 | $-0.00 | $-0.00 |
| EBITDA | -$314K | -$302K | -$9M | -$1M | $7K |
| Shares Outstanding | 105M | 298M | 482M | 629M | 827M |